IgE-Mediated Food Sensitization, Management Strategies, and Quality of Life in Pediatric Eosinophilic Esophagitis: A Prospective Observational Study
- PMID: 40573091
- PMCID: PMC12195944
- DOI: 10.3390/nu17121980
IgE-Mediated Food Sensitization, Management Strategies, and Quality of Life in Pediatric Eosinophilic Esophagitis: A Prospective Observational Study
Abstract
Background: Eosinophilic esophagitis is a chronic immune-mediated disease with increasing prevalence. In pediatric populations, it often coexists with IgE-mediated food sensitization. This dual diagnosis presents unique therapeutic challenges, including on the one hand both temporary and lifelong dietary restrictions, and on the other hand, therapeutic interventions with a potential impact on quality of life (QoL). Objectives: This study prospectively evaluated the prevalence of IgE-mediated food sensitization and allergy in children with EoE attending a tertiary center in Flanders, Belgium. Additionally, it prospectively documented dietary habits and restrictions in these children, with or without concomitant IgE-mediated food allergies, and assessed the impact of dietary management on quality of life compared to pharmacological treatment. Methods: We consecutively followed 30 children with biopsy-confirmed pediatric EoE (PedEoE) attending a tertiary referral center for at least 12 months. Patient demographics, allergy testing, dietary history, and treatment modalities were recorded. Symptom score and PedEoE QoL were assessed using validated Pediatric Eosinophilic Esophagitis Symptom Score (PEESS 2.0) and Pediatric Quality of Life Inventory (PedsQL 3.0) questionnaires. Statistical analysis was performed using the Mann-Whitney U test and Kruskal-Wallis test with Dunn's test as a post hoc test. Results: Among 30 children with EoE (60% male, median age 8 years), 60 PedEoE QoL (PedsQL) and 39 symptom (PEESS) questionnaires were collected at one or more time points over a median follow-up of 14.5 months. IgE sensitization to common dietary triggers was observed in multiple patients, with varying clinical reactivity. Symptom scores tended to be higher in children without histological remission, though differences were not statistically significant (median PEESS 23.75 vs. 17.50, p = 0.1934). Grouped by degree of dietary restriction, QoL scores showed significant differences (child p = 0.0102; parent p = 0.0203), with children in the 1-2 food elimination group reporting better QoL compared to the 0 food elimination and >6 food elimination groups. No clear statistically significant differences were observed between the 1-2 food elimination group and the 3-4 or 5-6 food elimination groups. Conclusions: IgE sensitization is prevalent among pediatric EoE patients and has significant clinical implications for disease management. Treatment choice can influence not only disease control but also the QoL of both patients and their families.
Keywords: QoL; food sensitization; pediatric eosinophilic esophagitis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Outcomes reported in randomized controlled trials for mixed and non-IgE-mediated food allergy: Systematic review.Clin Exp Allergy. 2023 May;53(5):526-535. doi: 10.1111/cea.14304. Epub 2023 Mar 7. Clin Exp Allergy. 2023. PMID: 36880564
-
Integrating PEESS, EREFS, and endoscopic ultrasonography in the multimodal management of pediatric eosinophilic esophagitis: A 4-year retrospective institutional experience.Medicine (Baltimore). 2025 Aug 8;104(32):e43803. doi: 10.1097/MD.0000000000043803. Medicine (Baltimore). 2025. PMID: 40797467 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3. Cochrane Database Syst Rev. 2016. PMID: 27030386 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Oliva S., Dias J.A., Rea F., Malamisura M., Espinheira M.C., Papadopoulou A., Koutri E., Rossetti D., Orel R., Homan M., et al. Characterization of Eosinophilic Esophagitis from the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN. J. Pediatr. Gastroenterol. Nutr. 2022;75:325–333. doi: 10.1097/MPG.0000000000003530. - DOI - PubMed
-
- Amil-Dias J., Oliva S., Papadopoulou A., Thomson M., Gutiérrez-Junquera C., Kalach N., Orel R., Auth M.K., Nijenhuis-Hendriks D., Strisciuglio C., et al. Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) J. Pediatr. Gastroenterol. Nutr. 2024;79:394–437. doi: 10.1002/jpn3.12188. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical